Gene signature may improve colon cancer treatment

A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study. The findings could help personalize treatments for colon cancer -- the second leading cause of cancer-related deaths in the United States -- by identifying patients most likely to benefit from chemotherapy.

Read the whole article on Science Daily

More from Science Daily